on August 12, 2004
Published online before print August 12, 2004, doi: 10.1161/01.STR.0000140632.83868.a2
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 4, 2004
From the Departments of Internal Medicine and Geratology (S.T.P.) and the Stroke Prevention Research Unit (P.M.R.), Department of Clinical Neurology, Radcliffe Infirmary, Oxford University, Oxford, UK; the Julius Centre for Health Sciences and Primary Care and the Department of Neurology (A.A., M.-J.A.), University Medical Centre of Utrecht, The Netherlands; the Department of Neurology 3 (G.B.), Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi, Istanbul, Turkey; the Department of Neurology (A.C., K.K.), Institute of Psychiatry and Neurology, Warsaw, Poland; the Department of Neurology Donauklinikum and the Centre for Neurosciences (A.D., M.B.), Donau University, Maria Gugging, Austria; the Department of Neurology (Y.K.), Medical Faculty, Istanbul University, Turkey; the Department of Neurology and Neurosurgery (J.K.), University of Tartu, Estonia; the University Department of Neurology (S.K.), Grodno State Medical University, Grodno, Belarus; the Department of Neurology (P.M., J.B.), University Hospital, Lausanne, Switzerland; and the Department of Neurology (L.T.), Haukeland University Hospital, Bergen, Norway. * To whom correspondence should be addressed. E-mail: peter.rothwell{at}clneuro.ox.ac.uk.
Background and Purpose--Previous studies in the United States and the United Kingdom have shown that stroke research is underfunded compared with coronary heart disease (CHD) and cancer research despite the high clinical and financial burden of stroke. We aimed to determine whether underfunding of stroke research is a Europe-wide problem. Methods--Data for the financial year 2000 to 2001 were collected from 9 different European countries. Information on stroke, CHD, and cancer research funding awarded by disease-specific charities and nondisease-specific charity or government- funded organizations was obtained from annual reports, web sites, and by direct communication with organizations. Results--There was marked and consistent underfunding of stroke research in all the countries studied. Stroke funding as a percentage of the total funding for stroke, CHD, and cancer was uniformly low, ranging from 2% to 11%. Funding for stroke was less than funding for cancer, usually by a factor of Conclusions--This study confirms that stroke research is grossly underfunded, compared with CHD and cancer, throughout Europe. Similar data have been obtained from the United States suggesting that relative underfunding of stroke research is likely to be a worldwide phenomenon.
Revised on April 23, 2004
Accepted on June 30, 2004
Underfunding of Stroke Research. A Europe-Wide Problem
Sarah T. Pendlebury BM, BCh, DPhil, MRCP;
10. In every country except Turkey, funding for stroke research was less than that for CHD.
Key words: coronary heart disease • health policy • neoplasms • public policy • stroke
This article has been cited by other articles:
 |
|
 |
|
  R. I. Lindley Is Intraarterial tPA Within 3 Hours the Treatment of Choice for Selected Stroke Patients?: No Stroke, July 1, 2009; 40(7): 2613 - 2614. [Full Text] [PDF]
|
|
|
|
|
|
S. C. Johnston The 2008 William M. Feinberg Lecture: Prioritizing Stroke Research Stroke, December 1, 2008; 39(12): 3431 - 3436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Verdecchia, P. Baili, A. Quaglia, I. Kunkler, R. Ciampichini, F. Berrino, and A. Micheli Patient survival for all cancers combined as indicator of cancer control in Europe Eur J Public Health, October 1, 2008; 18(5): 527 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Matchar and A. G. Rudd Health Policy and Outcomes Research 2004 Stroke, February 1, 2005; 36(2): 225 - 227. [Full Text] [PDF]
|
|